Appearance and Characterization of Lipoprotein X during Continuous Intralipid Infusions in the Neonate
- 1 December 1979
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 64 (6) , 1703-1712
- https://doi.org/10.1172/jci109633
Abstract
The development of hyperphospholipidemia and hypercholesterolemia was studied in infants that required total parenteral nutrition and given a continuous infusion of Intralipid, (1-4 g/kg body wt per 24 h. Detailed studies were carried out on infusion periods lasting 1-10 d. After 24 h there was a marked increase in plasma free cholesterol (68%) and phospholipid (77%) concentrations. Based on the amount of cholesterol in Intralipid, and the rate of infusion, it was estimated that at least 50% of the plasma cholesterol increment during 64-h infusions was derived from endogenous sources. By contrast, the hyperphospholipidemia could be attributed to the Intralipid as the rise in plasma was calculated to be equivalent to only 16% of the exogenous phospholipid infused. Approximately 10% of the phospholipid in Intralipid was in a triglyceride-free mesophase form with a free cholesterol:phospholipid molar ratio of 0.063. There were no systematic changes in plasma concentrations of cholesterol ester or triglyceride during Intralipid infusions. The increase in free cholesterol and phospholipid was localized in the low density lipoproteins (d = 1.006-1.063 g/ml). The presence of lipoprotein X (Lp-X) in the low density lipoprotein fraction was demonstrated by electrophoresis in agar and by isolation and chemical characterization with hydroxylapatite chromatography. Isoelectric focusing of urea-soluble protein of Lp-X revealed that albumin and apolipoproteins CII and CIII were major components, whereas apolipoprotein E and AI were minor constituents. The abnormal lipoprotein was apparent by 16 h during 64 h of infusion. After 6 d of continuous infusions the free cholesterol in Lp-X was 30±10 mg/dl (mean±SD), which represents a total Lp-X mass of 90 mg/dl. After cessation of the infusion, Lp-X, as monitored by electrophoresis in agar, disappeared within 72-96 h. Thus, during infusion of Intralipid in infants at rates commonly employed, the capacity of the clearance mechanisms for phospholipid are exceeded, which causes the accumulation of phospholipid and free cholesterol in the form of Lp-X particles. It is suggested that mesophase phospholipids in Intralipid may play a significant role in this process.This publication has 37 references indexed in Scilit:
- Identification of lipoprotein X-like particles in rat plasma following Intralipid infusionCanadian Journal of Biochemistry, 1979
- Secretion of lipoprotein-X by perfused livers of rats with cholestasis.Proceedings of the National Academy of Sciences, 1978
- Replacement of endogenous phospholipids in rat plasma lipoproteins during intravenous infusion of an artificial lipid emulsionCanadian Journal of Biochemistry, 1978
- Characterization of human very low density lipoproteins containing two electrophoretic populations: double pre-beta lipoproteinemia and primary dysbetalipoproteinemiaJournal of Lipid Research, 1977
- The effect of gestational age on Intralipid tolerancein newborn infantsThe Journal of Pediatrics, 1977
- Isolation, chemical characterization, and biophysical properties of three different abnormal lipoproteins: LP-X1, LP-X2, and LP-X3.Journal of Biological Chemistry, 1977
- Rapid Onset of Essential Fatty Acid Deficiency in the NewbornPediatrics, 1976
- Production of Hypercholesteremia in the Rabbit by Infusion of Phosphatide or Neutral Fat.Experimental Biology and Medicine, 1957
- Independence of Phosphatide Induced Hypercholesteremia and Hepatic Function.Experimental Biology and Medicine, 1956
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTJournal of Biological Chemistry, 1951